Natera · 4 weeks ago
Senior Engineering Manager — Lab Execution Platform : Oncology
Natera is a global leader in cell-free DNA testing dedicated to oncology, women’s health, and organ health. They are seeking a Senior Engineering Manager to lead the development and maintenance of their Lab Execution Platform, ensuring lab operations run efficiently and effectively while collaborating closely with lab scientists and R&D teams.
BiotechnologyLife ScienceHealthcareMedical DeviceFashionGeneticsHealth CareHealth DiagnosticsMedicalWomen's
Responsibilities
Own the design, build, and maintenance of both the off-the-shelf and custom Lab Execution platforms, keeping high-throughput lab processes running without a hitch
Build an AI-forward team that reaches for modern tooling to move faster and ship smarter
Stay hands-on—dive into the code and test the system yourself to make it better
Build and scale cloud-based microservices and front-end applications that power real lab workflows
Set the bar for technical excellence: reliability, performance, and a user experience people actually enjoy
Own the CI/CD pipeline and lock in quality with automated testing
Architect infrastructure that scales effortlessly and stays cost-smart
Be the bridge between engineering and lab users, turning real-time feedback into rapid improvements
Build tight relationships with Lab Operations, R&D, and stakeholders so their needs steer the roadmap
Run a nimble Kanban (or Scrum) workflow that flexes with the lab's evolving needs
Coach and grow a small, agile team, fueling their technical and professional development
Juggle priorities, deadlines, and resources—without dropping the bar on quality
Spark an ownership mindset so every engineer feels the impact of what they ship
Relentlessly streamline how the team works—maximum output, minimum overhead
Champion modular, cloud-native design as the default way you build
Watch performance closely, squash issues before they spread, and keep the platform rock-solid
Qualification
Required
10+ years building software applications
A track record of leading and growing high-performing engineering teams
Expertise in Python, TypeScript, and React, with strong front-end development chops
Proficiency with AWS services (Lambda, RDS, DynamoDB, S3, Glue) and infrastructure as code
Strong relational database skills (MySQL/PostgreSQL) and SQL programming
Experience with messaging frameworks such as Kafka
Sharp problem-solving instincts and a quality-first mindset
Excellent communication and stakeholder-management skills—you can speak engineer and non-engineer fluently
Preferred
Experience building custom LIMS/LES systems
Hands-on experience with LabVantage
Based in Austin, TX, to work shoulder-to-shoulder with lab operations and gather live feedback
Benefits
Comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
Free testing in addition to fertility care benefits for Natera employees and their immediate families
Pregnancy and baby bonding leave
401k benefits
Commuter benefits
Generous employee referral program
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
H1B Sponsorship
Natera has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
80%
Represents job field similar to this job
Engineering and Development
Product Management
Management and Executive
Customer Service and Support
Sales
Legal and Compliance
Creatives and Design
Accounting and Finance
Human Resources
Trends of Total Sponsorships
*2026 (13)
2025 (90)
2024 (72)
2023 (37)
2022 (71)
2021 (64)
2020 (40)
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Matthew Rabinowitz,Roelof BothaSofinnova InvestmentsHarmony Partners,OrbiMed
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Recent News
Medical Device Network
2026-08-07
2026-08-07
Company data provided by crunchbase